Table 1.
Clinical characteristics of patients in case group and control group
| Characteristics | Case group (n=50) | Control group (n=55) | P value |
|---|---|---|---|
| Age | 0.000 | ||
| > 55 | 28 | 25 | |
| ≤ 55 | 22 | 30 | |
| Gender | 0.249 | ||
| Male | 24 | 27 | |
| Female | 26 | 28 | |
| Basic cardiopulmonary diseases | 0.005 | ||
| Yes | 31 | 29 | |
| No | 19 | 26 | |
| Diagnosis | 0.773 | ||
| DLBCL | 34 | 37 | |
| Non-DLBCL | 16 | 18 | |
| Disease stage | 0.067 | ||
| limited stage | 17 | 19 | |
| Progressive stage | 33 | 36 | |
| Treatment | |||
| Including RTX | 39 | 41 | 0.000 |
| Not including RTX | 11 | 14 | |
| Liposome containing doxorubicin | 30 | 36 | 0.001 |
| Liposome-free doxorubicin | 20 | 19 |
Note: DLBCL: Diffuse large B-cell lymphoma; RTX: Rituximab.